Top Markets
Coin of the day
Odonate Therapeutics, Inc. Odonate Therapeutics, Inc.

Odonate Therapeutics, Inc.

ODTC
Rank in Stocks #18160
Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and... Odonate Therapeutics, Inc., a pharmaceutical company established in 2013 and headquartered in New York, New York, is dedicated to creating treatments for cancer. Its primary therapeutic in development is tesetaxel, an orally administered chemotherapy drug. This agent is currently undergoing a Phase III clinical study for its application in patients suffering from metastatic breast cancer.
Share Price
$150,000
Last synced: 2025-02-11
Market Cap
$210.38M
Change (1 day)
0.00%
Change (1 year)
0.00%
Country
US
Trade Odonate Therapeutics, Inc. (ODTC)

Category

Stock price history for Odonate Therapeutics, Inc. (ODTC)
Highest end of day price: $153.72K on 2025-02-01

Lowest end of day price: $1.89M on 2017-12-01
Stock price history of Odonate Therapeutics, Inc. from 2017 to 2026
Annual Stock Price Performance
Year Performance
2025 12.70%
2024 13.67%
2023 -10.92%
2022 10.41%
2021 -90.52%
2020 -48.22%
2019 119.33%
2018 -40.07%
2017 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$556.43 40.29%
US
$1.05K 45.39%
NL
$152.82 535.43%
US
$122.66 -9.24%
AU
$757.71 6.76%
CH